WALTHAM, Mass. –The ardor for Thermo Fisher Scientific stock appears to have returned to more normal levels. After reporting second quarter results in July, the company’s shares jumped more than 10%.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果